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Antipsychotics in dementia: are they being
appropriately prescribed?
In 2007, the U.K.’s All-Party Parliamentary Group
on Dementia (APPG) undertook an inquiry into
the prescription of antipsychotics for people with
dementia on account of concerns expressed by
carers, patient organizations and academics about
the appropriateness and safety of these drugs (All-
Party Parliamentary Group on Dementia, 2008).
It has been estimated that 32% of patients with de-
mentia in care homes are prescribed antipsychotics
(Alldred et al., 2007). Both typical and atypical
antipsychotics are associated with QT prolongation,
which can lead to arrhythmias and sudden death
(Joint Formulary Committee, 2009). They are also
associated with an increased risk of cerebrovascular
events. Adverse effects in the elderly include
excessive sedation and dizziness, which can lead to
falls and therefore accelerated cognitive decline.
Behavioral and psychological symptoms (BPSD)
are common in dementia, occurring in up to 80% of
cases (Ballard et al., 2008). They include agitation,
aggression, delusions, hallucinations, disinhibition,
irritability and aberrant motor behavior.
NICE guidelines state that antipsychotics should
only be considered for severe or agitated behavior
causing significant distress or if there is immediate
risk of harm to self or others (National Institute
for Health and Clinical Excellence, 2006). It is
therefore pertinent to discuss the anticipated use of
these drugs with patients and their carers. Target
symptoms should be identified and documented
and the subsequent change in these symptoms
should be assessed and recorded regularly. Treat-
ment with antipsychotics should be time-limited
and reviewed every three months or according to
clinical need. In 2008, the APPG acknowledged the
excessive prescription of antipsychotics and stressed
the importance of adhering to NICE guidelines
regarding the prescription of antipsychotics. They
also highlighted the need to audit the prescription
of antipsychotics in patients with dementia.
We identified patients referred to an Old Age
Psychiatric team based at The Queen Elizabeth
Psychiatric Hospital in Birmingham, U.K., using
medical and electronic records. All patients seen
between August 2005 and August 2007 who
received a DSM-IV (American Psychiatric Associ-
ation, 1994) diagnosis of dementia were included
in our audit. Medical notes were reviewed to
obtain: age; gender; type of dementia; MMSE score;
presenting symptoms; presence of BPSD; treatment
offered, including antipsychotics; duration of
pharmacological treatment; mean follow-up.
Seventy patients were identified. The study
population comprised 27 men and 43 women,
with a median age of 76 years. Thirteen (18.6%)
patients had mild cognitive impairment, 51 (72.9%)
moderate cognitive impairment and 6 (8.6%) severe
cognitive impairment. Fifty (71.4%) had BPSD
and antipsychotic medication was prescribed in
14 (28.0%) of these. Of these 14, 11 (78.6%)
received typical antipsychotics and 3 (21.4%)
atypical antipsychotics.
Of the 14 patients prescribed antipsychotics,
six (42.9%) were prescribed these drugs for less
than three months, three (21.4%) for three to
six months, and five (35.7%) for more than six
months. The maximum period for which any
patient took antipsychotics was eight months.
The remaining 36 patients with BPSD were not
prescribed antipsychotics.
A significant number of patients with dementia
who were seen by this Old Age Psychiatric service
presented with BPSD. The majority of these were
not treated with antipsychotics. This Old Age
Psychiatric team is adhering to NICE guidelines:
namely, the use of antipsychotics is limited to pa-
tients with severe BPSD, and antipsychotics are pre-
scribed to most patients for a limited period of time.
From our audit findings we believe that
clinicians would benefit from adopting the following
guidance:
• The risks and benefits of prescribing antipsychotics
should be reviewed prior to prescribing antipsychot-
ics in patients with dementia.
• Teams should document the BPSD for which
antipsychotics are prescribed.
• Teams should document discussions with patients
and their carers about antipsychotic prescriptions.
• A flagging system should be introduced to remind
clinicians to review antipsychotic prescriptions and
symptoms in patients with dementia every three
months.
• Clinical teams should regularly audit their
prescribing of antipsychotics in patients with
dementia.
Whilst there is much evidence regarding the
potential adverse effects of antipsychotics, their
benefit in relieving symptoms in patients with
dementia is also clear. The findings of the APPG
have highlighted the need for regulatory processes
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to ensure these drugs are used in an appropriate
and safe manner and audit is a simple and effective
means of achieving this.
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Old age psychiatry and geriatric medicine
admissions and elderly suicide rates in England
Almost all elderly suicide victims have mental
illness, and up to 90% have depression (Shah and
De, 1998). A significant number of elderly suicide
victims in Western countries consult their general
practitioner or psychiatrist or contact mental health
services between one week and six months prior
to the suicide (Catell, 1988; Conwell et al.,
1990; 1991; Catell and Jolley, 1995; Vassilas and
Morgan, 1993; 1994). This offers an opportunity
for identification and treatment of the mental illness.
Thus, the availability of appropriate healthcare
services may be an important factor associated with
elderly suicide rates.
High suicide rates in China (both rural areas
and Hong Kong), in part, have been attributed to
lack of mental health services and poorly developed
social welfare and benefit systems (Yip and Tan,
1998; Jianlin, 2000; Yip, 2001; Yip et al., 2000).
Moreover, reduction in elderly suicide rates in
Singapore and urban China have, in part, been
attributed to improved healthcare and welfare
services for the elderly (Kua et al., 2003; Yip
et al., 2005). A decline in elderly suicide rates in
England and Wales was associated with measures of
improved healthcare for the elderly (Gunnell et al.,
2003; Lodhi and Shah, 2005) including an increase
in the number of general practitioners, hospital
medical staff, outpatient appointments for mental
illness, and field social workers and day center
staff (Lodhi and Shah, 2005). However, in a cross-
national study elderly suicide rates were higher in
countries with greater numbers of psychiatric beds,
psychiatrists and psychiatric nurses (Shah and Bhat,
2008). The relationship between elderly suicide
rates and the utility of inpatient old age psychiatry
(OAP) services has not been examined. Therefore,
a study examining the relationship between elderly
suicide rates and the utility of inpatient geriatric
medicine (GM) and OAP services in England was
undertaken with the null hypothesis that there
will be no significant relationship between these
variables. GM was considered because a third of
GM inpatients have depression (Shah and Hoxey,
2000) and suicidal ideation (Shah et al., 2000).
Data on suicide rates in both sexes in the
age-bands 65–74 years and 75+ years for England
and Wales was ascertained from the World Health
Organization (WHO) website (http://www.who.int/
whosis/database/mort/table1.cfm) for each of the
nine calendar years between 1998 and 2006. Data
on the number of finished episodes (i.e. the number
of patients discharged with a completed inpatient
episode), median length of stay, and the number
of bed days for patients admitted to GM services
and OAP services in England was ascertained
from nationally collected data (Hospital Episode
Statistics, available at: www.hesonline.nhs.uk/Ease/
servlet/ContentServer?siteID=1937&CategoryID=
192). These national data are gathered centrally via
the patient administration systems in nearly 400
hospitals in England. Data were ascertained for the
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